Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) Director Gary W. Pace sold 5,015 shares of the business’s stock in a transaction dated Thursday, May 11th. The shares were sold at an average price of $41.78, for a total value of $209,526.70. Following the completion of the transaction, the director now owns 139,675 shares in the […]